First Patient Enrolled in TETON 2 Phase 3 Trial of Tyvaso for IPF
The first patient has been enrolled in a multinational Phase 3 clinical trial of Tyvaso for the treatment of idiopathic pulmonary fibrosis.
0 Comments
First Patient Enrolled in TETON 2 Phase 3 Trial of Tyvaso for IPF
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed